TMLEP Unveils a New Pre-Action Clinical Liability Investigation Service at APIL 2024
TMLEP at APIL 2024

TMLEP Unveils a New Pre-Action Clinical Liability Investigation Service at APIL 2024

TMLEP is excited to announce the launch of its pioneering Pre-Action Clinical Liability Investigation Service, unveiled today at the APIL Clinical Negligence Conference 2024 (APILCN24), where TMLEP will be the main sponsor.

This innovative service is set to revolutionise the way claimant lawyers approach early investigation of clinical negligence claims, offering an efficient, cost-effective solution that ensures claimants can access justice while remaining profitable under Fixed Recoverable Costs (FRC).

Key Features of the Pre-Action Clinical Liability Investigation Service:

  • No Agency Fees: With TMLEP’s direct investigation model, claimants and law firms can eliminate the financial risks of unrecoverable agency fees, helping to maintain the profitability of cases.

  • Unlimited Expert Opinions: The service covers an unlimited number of expert opinions from specialists across all medical disciplines, ensuring comprehensive assessments of clinical negligence claims.

  • Fixed Cost Investigations: Priced from £1,200 + VAT, the service provides fixed-cost reporting, making it compatible with the introduction of FRC, reducing disbursement costs and safeguarding recoverability.

  • Accelerated Case Resolution: Lawyers can rapidly produce a robust letter of claim, speeding up settlements and improving cash flow for both claimants and legal teams.

This Pre-Action Clinical Liability Investigation Service offers a new, streamlined method for determining the merits of a clinical negligence claim by providing precise, expert-driven insight on breach of duty and causation. With TMLEP’s global expertise, this service guarantees fast, thorough investigations that meet the highest standards.

About TMLEP

Founded in 2012, TMLEP is a leading provider of independent clinical investigations and expert evidence, advising on over 1,200 cases each month globally. With a team of specialist investigators and a network of over 3,000 medical specialists, TMLEP is dedicated to improving patient safety, enhancing healthcare standards, and supporting legal professionals with cutting-edge services that address the evolving needs of the industry.

For more information or to schedule a meeting at APIL 2024, please contact:

Nina Vegad LLB (Hons) SQE Lead Healthcare Investigator +44 203 355 9796 Ext: 219 [email protected]

Lisa Jones Director of Client Relations +44 203 355 9796 Ext: 239 [email protected]

www.tmlep.com